Infant Bacterial Therapeutics
Margareta Hagman is on the Board of Directors at Infant Bacterial Therapeutics. Margareta is Active as an Advisor and Consultant in Accounting and Finance and a Board member of TagMaster AB.
She previously worked as CFO and Deputy CEO of BioGaia AB, Board member of BioGaia Production AB, CapAble AB, and Annwall & Rothschild AB.
Margareta holds a Master of Business Administration from Örebro University.
This person is not in the org chart
Infant Bacterial Therapeutics
IBT is a clinical stage pharmaceutical company with a vision to develop drugs influencing the infant microbiome, and thereby prevent or treat rare diseases affecting infants.